)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
BiBBInstruments
BiBBInstruments (BIBB) investor relations material
BiBBInstruments Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary10 Feb, 2026
Executive summary
2025 marked a pivotal year, transitioning from clinical validation to commercial launch of EndoDrill® GI in the US with TaeWoong Medical USA, establishing first paying reference hospitals and scaling production for broader expansion in 2026.
Early sales signals included initial orders from UC Davis Health and further orders from TaeWoong, totaling approximately 401 KSEK in annual sales, with clinical presence and scientific support strengthened through studies and congress presentations.
The company secured additional patents in the US, China, and Japan, and achieved CE marking for the entire EndoDrill® family and FDA approval for EndoDrill® GI, reinforcing regulatory and commercial readiness.
Financially, a rights issue in January raised about 27.6 MSEK, and option exercises added further capital, enabling the US launch, production scale-up, and product portfolio development.
Focus for 2026 is on supporting a broader US launch, establishing a European distribution partnership, and expanding the EndoDrill® platform, particularly for lung cancer diagnostics.
Financial highlights
Q4 2025 net sales reached 253 KSEK (0 KSEK in Q4 2024); full-year net sales were 401 KSEK (0 KSEK in 2024).
Q4 result after financial items was -5,071 KSEK (-3,756 KSEK in Q4 2024); full-year result after financial items was -14,610 KSEK (-12,708 KSEK in 2024).
Earnings per share for Q4 was -0.12 SEK (-0.13 SEK in Q4 2024); for the year, -0.37 SEK (-0.45 SEK in 2024).
Cash and cash equivalents at year-end were 6,166 KSEK (3,377 KSEK in 2024); equity ratio was 93.6% (84.1% in 2024).
Total assets at year-end were 40,203 KSEK (33,728 KSEK in 2024).
Outlook and guidance
No sales forecasts are provided at this early commercialization stage, but the direction is clear with significant sales potential for EndoDrill® GI.
2026 will focus on broadening the US launch, entering the European market, and launching EndoDrill® EBUS for lung cancer, with clinical product release and FDA 510(k) submission planned.
A rights issue of approximately 60 MSEK is planned for early 2026 to fund continued commercialization and product development.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next BiBBInstruments earnings date
Q1 202629 Apr, 2026
BiBBInstruments
Next BiBBInstruments earnings date
Q1 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BiBBInstruments AB is a Sweden-based medical technology company focused on developing diagnostic devices for early cancer detection. The company’s flagship product, EndoDrill, is a series of innovative biopsy instruments designed to improve the precision and effectiveness of tissue sampling in endoscopic procedures. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage